Literature DB >> 27282216

Antibiotic-impregnated calcium phosphate cement as part of a comprehensive treatment for patients with established orthopaedic infection.

Takahiro Niikura1, Sang Yang Lee2, Takashi Iwakura2, Yoshitada Sakai3, Ryosuke Kuroda2, Masahiro Kurosaka2.   

Abstract

BACKGROUND: The treatment of established orthopaedic infection is challenging. While the main focus of treatment is wide surgical debridement, systemic and local antibiotic administration are important adjuvant therapies. Several reports have described the clinical use of antibiotic-impregnated calcium phosphate cement (CPC) to provide local antibiotic therapy for bone infections. However, these were all individual case reports, and no case series have been reported. We report a case series treated by a single surgeon using antibiotic-impregnated CPC as part of a comprehensive treatment plan in patients with established orthopaedic infection.
METHODS: We enrolled 13 consecutive patients with osteomyelitis (n = 6) or infected non-union (n = 7). Implantation of antibiotic-impregnated CPC was performed to provide local antibiotic therapy as part of a comprehensive treatment plan that also included wide surgical debridement, systemic antibiotic therapy, and subsequent second-stage reconstruction surgery. We investigated the rate of successful infection eradication and systemic/local complications. The concentration of antibiotics in the surgical drainage fluids, blood, and recovered CPC (via elution into a phosphate-buffered saline bath) were measured.
RESULTS: The mean follow-up period after surgery was 50.4 (range, 27-73) months. There were no cases of infection recurrence during follow-up. No systemic toxicity or local complications from the implantation of antibiotic-impregnated CPC were observed. The vancomycin concentration in the fluid from surgical drainage (n = 6) was 527.1 ± 363.9 μg/mL on postoperative day 1 and 224.5 ± 198.4 μg/mL on postoperative day 2. In patients who did not receive systemic vancomycin therapy (n = 3), the maximum serum vancomycin level was <0.8 μg/mL. In vitro vancomycin elution was observed from the CPC that was surgically retrieved (n = 2).
CONCLUSIONS: Implantation of antibiotic-impregnated CPC is an option to provide local antibiotic therapy as part of a comprehensive treatment plan.
Copyright © 2016 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27282216     DOI: 10.1016/j.jos.2016.05.003

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Antimicrobial Photodynamic Therapy Involving a Novel Photosensitizer Combined With an Antibiotic in the Treatment of Rabbit Tibial Osteomyelitis Caused by Drug-Resistant Bacteria.

Authors:  Xiujuan Yin; Ziyuan Fang; Yan Fang; Lin Zhu; Jinwen Pang; Tianjun Liu; Zhanjuan Zhao; Jianxi Zhao
Journal:  Front Microbiol       Date:  2022-04-22       Impact factor: 6.064

2.  Insights into treatment and outcome of fracture-related infection: a systematic literature review.

Authors:  H Bezstarosti; E M M Van Lieshout; L W Voskamp; K Kortram; W Obremskey; M A McNally; W J Metsemakers; M H J Verhofstad
Journal:  Arch Orthop Trauma Surg       Date:  2018-10-20       Impact factor: 3.067

3.  Novel nanographene oxide-calcium phosphate cement inhibits Enterococcus faecalis biofilm and supports dental pulp stem cells.

Authors:  Shizhou Wu; Michael D Weir; Lei Lei; Jun Liu; Hockin H K Xu
Journal:  J Orthop Surg Res       Date:  2021-10-09       Impact factor: 2.359

4.  In Vivo Release of Vancomycin from Calcium Phosphate Cement.

Authors:  Kentaro Uchida; Ken Sugo; Takehiko Nakajima; Mitsufumi Nakawaki; Shotaro Takano; Naoshige Nagura; Masashi Takaso; Ken Urabe
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

5.  A Case of Osteomyelitis after Calcaneal Fracture Treated by Antibiotic-Containing Calcium Phosphate Cements.

Authors:  Yoohak Kim; Fumiaki Inori; Kiyotaka Yamanaka; Shouichi Murakami; Eri Narita; Kazumasa Yamamura; Hiroyuki Yasuda; Makoto Fukuda; Sadahiko Konishi; Yukihide Minoda
Journal:  Case Rep Orthop       Date:  2018-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.